Investigation of Galangin against Gastric Cancer through PI3K/AKT/mTOR Signaling Pathway Modulation

Abstract Gastric cancer (GC) therapies are limited by severe adverse effects. Galangin, a natural flavonoid from galangal, shows anticancer activity, but its efficacy and mechanisms against GC remain incompletely defined. We evaluated galangin against GC in vitro and in vivo, focusing on PI3K/AKT/mTOR signaling. Galangin inhibited proliferation and migration of SNU719 and MKN45 cells while sparing GES-1 epithelial cells. In xenografts, galangin (60–120 mg/kg/day) significantly and dose-dependently suppressed tumor growth. Galangin elevated intracellular reactive oxygen species (ROS), reduced mitochondrial membrane potential, and triggered caspase-3 activation and mitochondrial apoptosis. Transcriptomic and network pharmacology analyses implicated PI3K/AKT/mTOR, apoptosis, cell cycle, and p53 pathways; immunoblotting and immunohistochemistry confirmed pathway inhibition in cells and tumors, respectively. These findings support galangin as a multitarget anti-GC candidate with a favorable safety profile relative to 5-FU.

Authors

Institutions

Publication Details

Journal
Journal of Agricultural and Food Chemistry
Published
2026-11-16
DOI
https://doi.org/10.1021/acs.jafc.6c06698
Primary Topic
PI3K/AKT/mTOR signaling in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Investigation of Galangin against Gastric Cancer through PI3K/AKT/mTOR Signaling Pathway Modulation

Yingzi Wu, Baojun Xu, Jian-Min Luo, Bo Han et al.
2 links
Journal of Agricultural and Food Chemistry
PI3K/AKT/mTOR signaling in cancer
article

Investigation of Galangin against Gastric Cancer through PI3K/AKT/mTOR Signaling Pathway Modulation

Yingzi Wu, Baojun Xu, Jian-Min Luo, Bo Han, Jinhai Luo
article en

Abstract

Abstract Gastric cancer (GC) therapies are limited by severe adverse effects. Galangin, a natural flavonoid from galangal, shows anticancer activity, but its efficacy and mechanisms against GC remain incompletely defined. We evaluated galangin against GC in vitro and in vivo, focusing on PI3K/AKT/mTOR signaling. Galangin inhibited proliferation and migration of SNU719 and MKN45 cells while sparing GES-1 epithelial cells. In xenografts, galangin (60–120 mg/kg/day) significantly and dose-dependently suppressed tumor growth. Galangin elevated intracellular reactive oxygen species (ROS), reduced mitochondrial membrane potential, and triggered caspase-3 activation and mitochondrial apoptosis. Transcriptomic and network pharmacology analyses implicated PI3K/AKT/mTOR, apoptosis, cell cycle, and p53 pathways; immunoblotting and immunohistochemistry confirmed pathway inhibition in cells and tumors, respectively. These findings support galangin as a multitarget anti-GC candidate with a favorable safety profile relative to 5-FU.

Journal of Agricultural and Food Chemistry
Beijing Normal-Hong Kong Baptist University (CN), Hong Kong Baptist University (HK), Guangzhou College of Technology and Business (CN)
Department of Education of Guangdong Province
Good health and well-being
PI3K/AKT/mTOR signaling in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon